Kane Biotech Inc Cash Flow Quality Index
Kane Biotech Inc cash flow quality index. Kane Biotech Inc (KNE) has a Cash Flow Quality Index of -0.24x as of June 2024. Operating cash flow of CA$-2.17 Million is below net income of CA$9.18 Million, suggesting accrual-heavy earnings not yet converted to cash. See Kane Biotech Inc (KNE) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Kane Biotech Inc (2024–2024)
Cash flow quality index of Kane Biotech Inc from 2024 to 2024. Historical Cash Flow Quality Index for Kane Biotech Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore KNE operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Kane Biotech Inc Cash Flow Quality Index by Year (2024–2024)
Kane Biotech Inc cash flow quality index by year from 2024 to 2024. Year-by-year earnings quality comparison for Kane Biotech Inc. For the full cash flow conversion analysis, see Kane Biotech Inc operating cash flow efficiency.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.67x | CA$-4.11 Million | CA$6.10 Million | — |